Health Canada warns against use of benzocaine products for children under two
The risk of methemoglobinemia in children is more significant than the potential benefits of benzocaine, especially as children may be incapable of communicating its related symptoms including weakness, confusion, headache and difficulty breathing, Health Canada said.